Pediatrix Medical Group, Inc. (MD) Earnings Call Transcript & Summary

Good morning, everyone. Will the meeting please come to order? I'm Mark Ordan, Chief Executive Officer and member of the Board of Directors of MEDNAX, Inc. Due to continued public health concerns resulting from the COVID-19 pandemic and to protect the health and safety of our shareholders, directors and employees, this year's annual meeting is being held in a virtual-only meeting format. [Technical Difficulty] Marc Richards, Executive Vice President and Chief Financial Officer; Dominic J. Andreano, Executive Vice President, General Counsel and Secretary for today's meeting; John C. Pepia, Senior Vice President and Chief Accounting Officer; and Dr. Mack Hinson, President of Pediatrix & Obstetrix Medical Groups. Charles Lynch and Meredith Longsworth will serve as inspectors for today's meeting. The notice of the meeting was given to shareholders of record on March 23, 2021. The record date for this meeting was March 10, 2021. Holders of common stock on that date are entitled to 1 vote per share on each matter that is submitted to the company's shareholders for approval. The list of shareholders of record of the company as of the close of business on March 10, 2021, is available for inspection by the shareholders upon request. The inspectors of election have informed me that more than a majority of the outstanding shares of common stock are present by proxy at this meeting. Therefore, a quorum is present, and I declare that this meeting is duly qualified to transact business. This meeting has been called to order to take action upon: first, the election of 11 directors to serve until the next Annual Meeting of Shareholders or until their respective successors are duly elected and qualified; second, a proposal to approve the amendment and restatement of the company's amended and restated 2008 incentive compensation plan; third, our proposal to approve the amendment and restatement of the company's 1996 nonqualified employee stock purchase plan as amended; ratification of the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the 2021 year; the approval, on an advisory basis, of the compensation for the company's named executive officers as disclosed in the company's proxy statement; and finally, to consider and act upon any other business that may properly come before the meeting and any adjournments thereof. The polls are now open for you to vote. If you previously voted by proxy, you do not need to vote again. If you were voting today, you must ensure you submit your electronic ballots in order for your votes to be counted. The inspector of election will not accept votes submitted after the closing of the polls. Please note that any votes submitted via an electronic ballot will be subject to final verification by the inspectors of election. [Voting]

All shareholders attending or by proxy have now had the chance to vote, and the polls are declared closed. The inspectors have provided me with the preliminary voting results, and I report that the shareholders have elected all of the nominated to the Board of Directors, approved the amendment and restatement of the company's amended and restated 2008 incentive compensation plan, approved the amendment and restatement of the company's 1996 nonqualified employee stock purchase plan as amended, ratified the appointment of PricewaterhouseCoopers as our public accounting firm, and approved the compensation of our named executive officers. Is there any other business to come before this meeting today? If there's no other business, is there a motion to adjourn this meeting?

So moved.

Is there a second?

Second.

Thank you. The business portion of the Annual Meeting of the Shareholders of MEDNAX, Inc. for 2021 is now adjourned. At this time, we will be happy to answer any questions you may have. In addition to our officers and directors, please note that representatives of PricewaterhouseCoopers are attending today, and they are available to respond to appropriate questions. If you wish to ask a question, please click on the message icon on your screen. It is possible that today's meeting, including some of our comments and some of our responses to your questions, may include forward-looking statements that are based on certain assumptions and is subject to a number of risks and uncertainties, including risks and uncertainties that are included in the company's SEC reports, and we assume no responsibility for updating any forward-looking statements. Are there any questions?

No questions.

There are no questions. So at this time, if there are no other questions, this meeting is now adjourned. I thank you for your attendance. Stay safe.